title: Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
abstract: The aim of this study is to investigate the effect of one-course chemotherapy on the pulmonary epithelial permeability. Eighteen patients (18 male; mean age: 59+/-10 years) with lung cancer (11 non-small cell, 7 small cell) inhaled 40 mCi (1,480 MBq) (99m)Tc-diethylenetriaminepentaacetic acid (DTPA). Thirty images of 1-min duration were acquired from posterior projection. The first 7 min of the decay-corrected time activity curves were used to calculate lung clearance half-time. Clearance half-times of (99m)Tc-DTPA from the peripheral regions of the lungs were 42+/-19 min before and 56+/-34 min after chemotherapy (p=0.009); from the central regions, clearance half-times were 112+/-94 min before and 160+/-125 min after chemotherapy (p=0.005). This decrease in clearance rate might be related to decreasing mucociliary clearance rate due to the toxic effect of the chemotherapy regimen on cilia movement and/or mucus structure. (99m)Tc-DTPA radioaerosol study can be used to monitor the toxic effects of chemotherapy on the pulmonary epithelium and possibly on mucociliary function.
authors.affiliation: Department of Nuclear Medicine, Celal Bayar University School of Medicine, Manisa, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Sayit
authors.forename: S
authors.initials: S
authors.lastname: Aktoğu
authors.forename: T
authors.initials: T
authors.lastname: Ertay
authors.forename: G
authors.initials: G
authors.lastname: Capa
authors.forename: G
authors.initials: G
authors.lastname: Erkmen
authors.forename: E
authors.initials: E
authors.lastname: Ozbilek
authors.forename: M
authors.initials: M
authors.lastname: Büyükşirin
authors.forename: H
authors.initials: H
authors.lastname: Durak
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000378:metabolism*; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008168:Lung / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009079:Mucociliary Clearance / Q000187:drug effects; D020545:Respiratory Mucosa / Q000187:drug effects / Q000378:metabolism*; D016284:Technetium Tc 99m Pentetate / Q000008:administration & dosage / Q000493:pharmacokinetics; D014797:Vital Capacity / Q000187:drug effects
chemical_list: D016685:Mitomycin; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin; D007069:Ifosfamide; D016284:Technetium Tc 99m Pentetate